BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2317483)

  • 1. Effects of hypoxia and fatty acids on the distribution of metabolites in rat heart.
    Hütter JF; Alves C; Soboll S
    Biochim Biophys Acta; 1990 Apr; 1016(2):244-52. PubMed ID: 2317483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of adenine nucleotide translocase in O2-deficient hearts.
    Pande SV; Goswami T; Parvin R
    Am J Physiol; 1984 Jul; 247(1 Pt 2):H25-34. PubMed ID: 6331205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
    Lopaschuk GD; Wall SR; Olley PM; Davies NJ
    Circ Res; 1988 Dec; 63(6):1036-43. PubMed ID: 3197271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle.
    Bielefeld DR; Vary TC; Neely JR
    J Mol Cell Cardiol; 1985 Jun; 17(6):619-25. PubMed ID: 3927008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid intermediates in chronically volume-overloaded rat hearts. Effect of diffuse ischemia.
    Bowe C; Nzonzi J; Corsin A; Moravec J; Feuvray D
    Pflugers Arch; 1984 Nov; 402(3):317-20. PubMed ID: 6240633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid metabolism in hearts containing elevated levels of CoA.
    Lopaschuk GD; Hansen CA; Neely JR
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H351-9. PubMed ID: 3953832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-mediated impairment of normal energy metabolism in the isolated perfused diabetic rat heart studied by phosphorus-31 NMR and chemical extraction.
    Pieper GM; Salhany JM; Murray WJ; Wu ST; Eliot RS
    Biochim Biophys Acta; 1984 Apr; 803(4):229-40. PubMed ID: 6704434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy-linked regulation of mitochondrial fatty acid oxidation in the isolated perfused rat heart.
    Latipää PM
    J Mol Cell Cardiol; 1989 Aug; 21(8):765-71. PubMed ID: 2778813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of fatty acid metabolism in ischemic and hypoxic hearts.
    Whitmer JT; Idell-Wenger JA; Rovetto MJ; Neely JR
    J Biol Chem; 1978 Jun; 253(12):4305-9. PubMed ID: 659417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid. A phosphorus-31 NMR and chemical extract study.
    Pieper GM; Murray WJ; Salhany JM; Wu ST; Eliot RS
    Biochim Biophys Acta; 1984 Apr; 803(4):241-9. PubMed ID: 6704435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of long chain fatty acids in the normal and pathologic heart: effects of ischemia].
    Feuvray D; Leblond Y
    Diabete Metab; 1984 Dec; 10(5):316-23. PubMed ID: 6397367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
    Alam N; Saggerson ED
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detrimental actions of endogenous fatty acids and their derivatives. A study of ischaemic mitochondrial injury.
    Piper HM; Das A
    Basic Res Cardiol; 1987; 82 Suppl 1():187-96. PubMed ID: 2821981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine.
    Wang Y; Christopher BA; Wilson KA; Muoio D; McGarrah RW; Brunengraber H; Zhang GF
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E622-E633. PubMed ID: 30016154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine metabolism in livers and hearts of 48h-starved rats: the contribution of fat and carbohydrate to acylcarnitine formation.
    French TJ; Goode AW; Holness MJ; Sugden MC
    Biochem Int; 1985 Aug; 11(2):265-72. PubMed ID: 4052090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: chemical and phosphorus-31 NMR evidence.
    Pieper GM; Murray WJ
    Biochem Med Metab Biol; 1987 Aug; 38(1):111-20. PubMed ID: 3663394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart.
    Kobayashi A; Fujisawa S
    J Mol Cell Cardiol; 1994 Apr; 26(4):499-508. PubMed ID: 8072006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of coenzyme A and carnitine on steady-state ATP/ADP ratios and the rate of long-chain free fatty acid oxidation in liver mitochondria.
    Christiansen EN; Davis EJ
    Biochim Biophys Acta; 1978 Apr; 502(1):17-28. PubMed ID: 638140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic products and myocardial ischemia.
    Neely JR; Feuvray D
    Am J Pathol; 1981 Feb; 102(2):282-91. PubMed ID: 7008624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.